Informations générales (source: ClinicalTrials.gov)
Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome : Autism Spectrum Quotient (AQ) Empathy Quotient (EQ) and Systemizing Quotient (SQ)
Observational
Groupe Francais d'Epidemiologie Psychiatrique (Voir sur ClinicalTrials)
juillet 2007
juillet 2009
29 juin 2024
Autism is considered as an invading disorder of the development. Asperger Syndrome (AS)
is a particular form of autism and is difficult to diagnose. The Autism Spectrum Quotient
(AQ) has been developed in order to measure the degree of autistic traits in autistic
adolescent with normal intelligence (Baron-Cohen et al. 2001, 2006). AQ comprises 50
questions, with 5 groups of 10 questions assessing imagination, social skills, attention
switching, attention to detail and communication skills. Each of these items scores 1
point if the respondent records abnormal or autistic like behaviour. The minimum score on
the AQ is 0 and the maximum 50.
The principal objective of this study is to evaluate the accuracy of the French version
of Autism Spectrum Quotient questionnaire.
Secondary objectives are to:
Evaluate if EQ and SQ can distinguish adolescents without psychiatric syndromes from
those with classical autism or AS.
Evaluate if AQ, EQ and SQ can distinguish adolescents with psychiatric disorders from
autistic adolescents.
Define the threshold of positivity for the 3 questionnaires.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Centre Hospitalier Saint Jean de Dieu - Lyon - France | Sabine Manificat, MDH | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
Group 1 (AS/HFA) and 2 (AS/classic autism) :
- Boys and girls aged 12 to 18
- Patients with autism or Asperger syndrome according to the diagnostic criteria (ICD
10)
- Patients receiving education in an ordinary school
- IQ>70
Group 3 (adolescents with psychiatric disorders):
- Boys and girls aged 12 to 18
- Patients hospitalized on a psychiatric ward or at a psychiatrics patient visit or
psychiatric consultation wit hout autistic syndrome
- Patients receiving education in an ordinary school when not in hospital
Group 4 (adolescent without psychiatric syndrome):
- Boys and girls aged 12 to 18
- Patients receiving education in an ordinary school
Group 1 (AS/HFA) and 2 (AS/classic autism) :
- Boys and girls aged 12 to 18
- Patients with autism or Asperger syndrome according to the diagnostic criteria (ICD
10)
- Patients receiving education in an ordinary school
- IQ>70
Group 3 (adolescents with psychiatric disorders):
- Boys and girls aged 12 to 18
- Patients hospitalized on a psychiatric ward or at a psychiatrics patient visit or
psychiatric consultation wit hout autistic syndrome
- Patients receiving education in an ordinary school when not in hospital
Group 4 (adolescent without psychiatric syndrome):
- Boys and girls aged 12 to 18
- Patients receiving education in an ordinary school
For all groups :
- Problem with language or comprehension
- Participants who have not given their consent